State Cancer Profiles

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Oral Cavity & Pharynx (Late Stage^), 2018-2022

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Count

Explanation of Column Headers
Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.

Other Notes

• Larger confidence intervals indicate less stability of the data. This is often due to low counts that are not quite low enough to be suppressed.
• Data is currently being suppressed if there are fewer than 16 counts for the time period.

Line by Line Interpretation of the Report

US (SEER+NPCR)¹

• Rate : The incidence rate is 7.7 with a 95% confidence interval from 7.7 to 7.8 and 32,341 average annual cases over 2018-2022.
• CI*Rank ⋔ : N/A

California⁷

• Rate : The incidence rate is 6.7 with a 95% confidence interval from 6.5 to 6.8 and 3,078 average annual cases over 2018-2022.
• CI*Rank ⋔ : 44 (41, 47)
• Percent of Cases with Late Stage :

Florida²

• Rate : The incidence rate is 8.8 with a 95% confidence interval from 8.6 to 8.9 and 2,735 average annual cases over 2018-2022.
• CI*Rank ⋔ : 10 (6, 17)
• Percent of Cases with Late Stage :

Texas⁷

• Rate : The incidence rate is 7.3 with a 95% confidence interval from 7.2 to 7.5 and 2,320 average annual cases over 2018-2022.
• CI*Rank ⋔ : 33 (30, 40)
• Percent of Cases with Late Stage :

New York⁷

• Rate : The incidence rate is 7.2 with a 95% confidence interval from 7.1 to 7.4 and 1,878 average annual cases over 2018-2022.
• CI*Rank ⋔ : 36 (31, 42)
• Percent of Cases with Late Stage :

Pennsylvania²

• Rate : The incidence rate is 8.0 with a 95% confidence interval from 7.8 to 8.2 and 1,424 average annual cases over 2018-2022.
• CI*Rank ⋔ : 23 (17, 30)
• Percent of Cases with Late Stage :

Ohio²

• Rate : The incidence rate is 8.7 with a 95% confidence interval from 8.5 to 8.9 and 1,345 average annual cases over 2018-2022.
• CI*Rank ⋔ : 12 (6, 19)
• Percent of Cases with Late Stage :

Illinois⁷

• Rate : The incidence rate is 7.9 with a 95% confidence interval from 7.7 to 8.1 and 1,275 average annual cases over 2018-2022.
• CI*Rank ⋔ : 24 (18, 31)
• Percent of Cases with Late Stage :

North Carolina²

• Rate : The incidence rate is 8.6 with a 95% confidence interval from 8.4 to 8.9 and 1,146 average annual cases over 2018-2022.
• CI*Rank ⋔ : 14 (6, 20)
• Percent of Cases with Late Stage :

Georgia⁷

• Rate : The incidence rate is 8.6 with a 95% confidence interval from 8.4 to 8.9 and 1,092 average annual cases over 2018-2022.
• CI*Rank ⋔ : 13 (6, 20)
• Percent of Cases with Late Stage :

Michigan²

• Rate : The incidence rate is 7.9 with a 95% confidence interval from 7.7 to 8.2 and 1,064 average annual cases over 2018-2022.
• CI*Rank ⋔ : 25 (18, 32)
• Percent of Cases with Late Stage :

New Jersey⁷

• Rate : The incidence rate is 7.2 with a 95% confidence interval from 7.0 to 7.5 and 874 average annual cases over 2018-2022.
• CI*Rank ⋔ : 38 (30, 43)
• Percent of Cases with Late Stage :

Virginia²

• Rate : The incidence rate is 7.2 with a 95% confidence interval from 7.0 to 7.5 and 776 average annual cases over 2018-2022.
• CI*Rank ⋔ : 37 (30, 43)
• Percent of Cases with Late Stage :

Indiana²

• Rate : The incidence rate is 8.8 with a 95% confidence interval from 8.5 to 9.1 and 736 average annual cases over 2018-2022.
• CI*Rank ⋔ : 9 (4, 19)
• Percent of Cases with Late Stage :

Washington¹

• Rate : The incidence rate is 7.8 with a 95% confidence interval from 7.5 to 8.0 and 734 average annual cases over 2018-2022.
• CI*Rank ⋔ : 28 (20, 34)
• Percent of Cases with Late Stage :

Tennessee²

• Rate : The incidence rate is 8.3 with a 95% confidence interval from 8.0 to 8.5 and 728 average annual cases over 2018-2022.
• CI*Rank ⋔ : 20 (12, 28)
• Percent of Cases with Late Stage :

Missouri²

• Rate : The incidence rate is 9.2 with a 95% confidence interval from 8.9 to 9.5 and 726 average annual cases over 2018-2022.
• CI*Rank ⋔ : 5 (2, 12)
• Percent of Cases with Late Stage :

Massachusetts²

• Rate : The incidence rate is 7.5 with a 95% confidence interval from 7.2 to 7.7 and 689 average annual cases over 2018-2022.
• CI*Rank ⋔ : 32 (25, 41)
• Percent of Cases with Late Stage :

Wisconsin²

• Rate : The incidence rate is 8.1 with a 95% confidence interval from 7.8 to 8.4 and 638 average annual cases over 2018-2022.
• CI*Rank ⋔ : 22 (15, 31)
• Percent of Cases with Late Stage :

South Carolina²

• Rate : The incidence rate is 8.7 with a 95% confidence interval from 8.4 to 9.0 and 598 average annual cases over 2018-2022.
• CI*Rank ⋔ : 11 (5, 21)
• Percent of Cases with Late Stage :

Kentucky⁷

• Rate : The incidence rate is 9.8 with a 95% confidence interval from 9.5 to 10.2 and 567 average annual cases over 2018-2022.
• CI*Rank ⋔ : 2 (1, 5)
• Percent of Cases with Late Stage :

Arizona²

• Rate : The incidence rate is 5.9 with a 95% confidence interval from 5.7 to 6.1 and 550 average annual cases over 2018-2022.
• CI*Rank ⋔ : 48 (46, 51)
• Percent of Cases with Late Stage :

Maryland²

• Rate : The incidence rate is 7.0 with a 95% confidence interval from 6.7 to 7.2 and 544 average annual cases over 2018-2022.
• CI*Rank ⋔ : 41 (34, 46)
• Percent of Cases with Late Stage :

Minnesota²

• Rate : The incidence rate is 7.3 with a 95% confidence interval from 7.0 to 7.6 and 525 average annual cases over 2018-2022.
• CI*Rank ⋔ : 35 (27, 43)
• Percent of Cases with Late Stage :

Louisiana⁷

• Rate : The incidence rate is 9.1 with a 95% confidence interval from 8.7 to 9.4 and 515 average annual cases over 2018-2022.
• CI*Rank ⋔ : 6 (3, 16)
• Percent of Cases with Late Stage :

Colorado²

• Rate : The incidence rate is 6.9 with a 95% confidence interval from 6.6 to 7.2 and 470 average annual cases over 2018-2022.
• CI*Rank ⋔ : 43 (35, 46)
• Percent of Cases with Late Stage :

Oregon²

• Rate : The incidence rate is 7.9 with a 95% confidence interval from 7.5 to 8.2 and 441 average annual cases over 2018-2022.
• CI*Rank ⋔ : 26 (17, 35)
• Percent of Cases with Late Stage :

Alabama²

• Rate : The incidence rate is 6.5 with a 95% confidence interval from 6.2 to 6.8 and 424 average annual cases over 2018-2022.
• CI*Rank ⋔ : 46 (41, 48)
• Percent of Cases with Late Stage :

Oklahoma²

• Rate : The incidence rate is 8.5 with a 95% confidence interval from 8.1 to 8.9 and 401 average annual cases over 2018-2022.
• CI*Rank ⋔ : 16 (6, 25)
• Percent of Cases with Late Stage :

Connecticut⁷

• Rate : The incidence rate is 7.7 with a 95% confidence interval from 7.4 to 8.1 and 379 average annual cases over 2018-2022.
• CI*Rank ⋔ : 30 (19, 39)
• Percent of Cases with Late Stage :

Iowa⁷

• Rate : The incidence rate is 9.0 with a 95% confidence interval from 8.5 to 9.4 and 365 average annual cases over 2018-2022.
• CI*Rank ⋔ : 8 (3, 19)
• Percent of Cases with Late Stage :

Arkansas²

• Rate : The incidence rate is 9.3 with a 95% confidence interval from 8.8 to 9.7 and 353 average annual cases over 2018-2022.
• CI*Rank ⋔ : 3 (1, 15)
• Percent of Cases with Late Stage :

Mississippi²

• Rate : The incidence rate is 8.5 with a 95% confidence interval from 8.0 to 8.9 and 315 average annual cases over 2018-2022.
• CI*Rank ⋔ : 17 (5, 27)
• Percent of Cases with Late Stage :

Kansas²

• Rate : The incidence rate is 7.8 with a 95% confidence interval from 7.4 to 8.2 and 278 average annual cases over 2018-2022.
• CI*Rank ⋔ : 27 (17, 39)
• Percent of Cases with Late Stage :

West Virginia²

• Rate : The incidence rate is 10.1 with a 95% confidence interval from 9.5 to 10.7 and 258 average annual cases over 2018-2022.
• CI*Rank ⋔ : 1 (1, 5)
• Percent of Cases with Late Stage :

Nevada²

• Rate : The incidence rate is 5.8 with a 95% confidence interval from 5.4 to 6.1 and 224 average annual cases over 2018-2022.
• CI*Rank ⋔ : 49 (46, 51)
• Percent of Cases with Late Stage :

Puerto Rico²

• Rate : The incidence rate is 4.4 with a 95% confidence interval from 4.1 to 4.7 and 210 average annual cases over 2018-2022.
• CI*Rank ⋔ : N/A
• Percent of Cases with Late Stage :

Maine²

• Rate : The incidence rate is 9.3 with a 95% confidence interval from 8.7 to 9.9 and 197 average annual cases over 2018-2022.
• CI*Rank ⋔ : 4 (1, 19)
• Percent of Cases with Late Stage :

Nebraska²

• Rate : The incidence rate is 7.5 with a 95% confidence interval from 7.0 to 8.1 and 178 average annual cases over 2018-2022.
• CI*Rank ⋔ : 31 (18, 43)
• Percent of Cases with Late Stage :

New Hampshire²

• Rate : The incidence rate is 8.6 with a 95% confidence interval from 8.0 to 9.2 and 174 average annual cases over 2018-2022.
• CI*Rank ⋔ : 15 (3, 29)
• Percent of Cases with Late Stage :

New Mexico⁷

• Rate : The incidence rate is 6.2 with a 95% confidence interval from 5.8 to 6.6 and 169 average annual cases over 2018-2022.
• CI*Rank ⋔ : 47 (42, 50)
• Percent of Cases with Late Stage :

Idaho⁷

• Rate : The incidence rate is 7.3 with a 95% confidence interval from 6.8 to 7.9 and 168 average annual cases over 2018-2022.
• CI*Rank ⋔ : 34 (21, 45)
• Percent of Cases with Late Stage :

Utah⁷

• Rate : The incidence rate is 5.4 with a 95% confidence interval from 5.0 to 5.8 and 164 average annual cases over 2018-2022.
• CI*Rank ⋔ : 51 (47, 51)
• Percent of Cases with Late Stage :

Hawaii⁷

• Rate : The incidence rate is 8.1 with a 95% confidence interval from 7.5 to 8.7 and 155 average annual cases over 2018-2022.
• CI*Rank ⋔ : 21 (6, 38)
• Percent of Cases with Late Stage :

Montana²

• Rate : The incidence rate is 7.8 with a 95% confidence interval from 7.1 to 8.5 and 117 average annual cases over 2018-2022.
• CI*Rank ⋔ : 29 (10, 43)
• Percent of Cases with Late Stage :

Delaware²

• Rate : The incidence rate is 8.4 with a 95% confidence interval from 7.7 to 9.1 and 116 average annual cases over 2018-2022.
• CI*Rank ⋔ : 18 (3, 36)
• Percent of Cases with Late Stage :

Rhode Island²

• Rate : The incidence rate is 7.2 with a 95% confidence interval from 6.6 to 7.9 and 107 average annual cases over 2018-2022.
• CI*Rank ⋔ : 39 (20, 47)
• Percent of Cases with Late Stage :

Vermont²

• Rate : The incidence rate is 9.0 with a 95% confidence interval from 8.1 to 10.0 and 83 average annual cases over 2018-2022.
• CI*Rank ⋔ : 7 (1, 29)
• Percent of Cases with Late Stage :

South Dakota²

• Rate : The incidence rate is 7.2 with a 95% confidence interval from 6.5 to 8.0 and 79 average annual cases over 2018-2022.
• CI*Rank ⋔ : 40 (18, 47)
• Percent of Cases with Late Stage :

Alaska²

• Rate : The incidence rate is 8.4 with a 95% confidence interval from 7.5 to 9.3 and 69 average annual cases over 2018-2022.
• CI*Rank ⋔ : 19 (2, 41)
• Percent of Cases with Late Stage :

North Dakota²

• Rate : The incidence rate is 6.9 with a 95% confidence interval from 6.1 to 7.7 and 64 average annual cases over 2018-2022.
• CI*Rank ⋔ : 42 (21, 49)
• Percent of Cases with Late Stage :

District of Columbia²

• Rate : The incidence rate is 6.6 with a 95% confidence interval from 5.7 to 7.5 and 44 average annual cases over 2018-2022.
• CI*Rank ⋔ : 45 (24, 51)
• Percent of Cases with Late Stage :

Wyoming²

• Rate : The incidence rate is 5.5 with a 95% confidence interval from 4.7 to 6.3 and 41 average annual cases over 2018-2022.
• CI*Rank ⋔ : 50 (44, 51)
• Percent of Cases with Late Stage :

Notes:
Created by statecancerprofiles.cancer.gov on 03/17/2026 1:08 am.

State Cancer Registries may provide more current or more local data.



† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (SEER areas use 20 age groups and NPCR areas use 19 age groups). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage with Expanded Regional Codes (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. The rates used in CI*Rank are all age-adjusted to the 2000 US standard population using 19 age groups for SEER and NPCR areas. More information about methodology can be found on the CI*Rank website.

¹ Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2024 submission.

² Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2024 submission).

⁷ Source: SEER November 2024 submission.

Data for United States does not include Puerto Rico.